EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways

Narayan Acharya, Ramji Kandel, Priti Roy, Irfan Warraich, Kamaleshwar P Singh

European Journal of Pharmaceutical Sciences · 2025

DOI: 10.1016/j.ejps.2024.106977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025. Verfasst von Narayan Acharya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Toxicology, Texas Tech University, Lubbock, TX 79409, United States. Hauptthemen laut MEDLINE: Fibrosis, Epigenesis, Genetic, Folic Acid, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisEpigenesis, GeneticFolic AcidSignal TransductionAcute Kidney InjuryHydroxamic AcidsDecitabineKidneyAnimalsHumansMaleCell LineMiceDNA MethylationHistone Deacetylase InhibitorsMice, Inbred C57BLEpithelial-Mesenchymal TransitionArsenic

Stichwörter der Autor:innen

ArsenicDNA methylationEpigeneticsFibrogenic signalingFolic acidHistone modificationsKidney fibrosis

Substanzen

Folic AcidHydroxamic AcidsDecitabinetrichostatin AHistone Deacetylase InhibitorsArsenic

Autor:innen und Institutionen

  • Department of Environmental Toxicology, Texas Tech University, Lubbock, TX 79409, United States.
  • Department of Pathology, Texas Tech University Health Science Center, Lubbock, TX 79430, United States.
  • Department of Environmental Toxicology, Texas Tech University, Lubbock, TX 79409, United States. Electronic address: kamaleshwar.singh@ttu.edu.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Acharya, N., Kandel, R., Roy, P., Warraich, I., & Singh, K. P. (2025). Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106977

Vancouver

Acharya N, Kandel R, Roy P, Warraich I, Singh KP. Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways. European Journal of Pharmaceutical Sciences. 2025. doi:10.1016/j.ejps.2024.106977

BibTeX
@article{Acharya2025,
  author = {Acharya, Narayan and Kandel, Ramji and Roy, Priti and Warraich, Irfan and Singh, Kamaleshwar P},
  title = {Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2025},
  doi = {10.1016/j.ejps.2024.106977}
}
Kostenlos starten →